Effects of Repetitive Transcranial Magnetic Stimulation on Two Cerebellar Targets
This study wants to learn how certain parts of the brain, called the cerebellum, help with movement and thinking. Researchers will use a gentle brain stimulation technique called rTMS on healthy volunteers. They will stimulate two different areas of the cerebellum to see how it affects brain activity and performance in tasks. One area is linked to movement, and the other to attention and thinking. The study is double-blind, meaning neither the participants nor the researchers know who is getting active stimulation or a placebo. The results will help scientists understand the brain better and develop improved treatments for people with brain-related health problems.
At a glance
What is this study about?
This research is all about understanding a part of your brain called the cerebellum, which helps with many important jobs like moving your body and even how you think. Scientists know that a gentle brain stimulation method, called repetitive Transcranial Magnetic Stimulation (rTMS), can be helpful for certain brain conditions, but they want to learn more about exactly how it works.
In this study, researchers will use rTMS to stimulate two specific areas in the cerebellum of healthy volunteers. One area, called Lobule VIII, is thought to be involved in movement and learning new physical skills. The other area, named CRUS I/II, is believed to play a role in attention, thinking clearly, and even judging time. By comparing how stimulating these two different areas affects people, the scientists hope to get a clearer picture of what each part does and how they can be influenced.
The main goal is to gather information that will help create better ways to treat brain conditions in the future. Even though participants won't get direct medical benefits, their involvement is really important for advancing our understanding of the brain and developing new and more effective therapies for patients with various neurological and psychiatric issues.
Key takeaways
- This study uses gentle brain stimulation (rTMS) to understand how different brain areas work.
- It aims to discover how specific parts of the cerebellum affect movement and thinking.
- Healthy volunteers are needed to help develop better treatments for brain conditions.
- You'll have three short study visits involving brain scans and computer tasks.
- Risks are minimal, mainly temporary headaches, and you can withdraw anytime.
Who may be eligible?
To be part of this study, you need to be a healthy adult between the ages of 18 and 60. You should also be covered by a health insurance plan.
There are several reasons why someone might not be able to join. For instance, if you have a history of drug or alcohol misuse, or if you've taken certain medications recently. If you have any neurological conditions like epilepsy, or other brain health issues like ADHD or Borderline Personality Disorder, you won't be able to take part. Also, if you have severe vision problems that can't be corrected, this study won't be suitable.
It's also important that you don't have any metal in your body that can't be removed, like certain implants or pacemakers, as these can make MRI scans and rTMS unsafe. Pregnant or breastfeeding women cannot participate, and you shouldn't be involved in another clinical study at the same time.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you between 18 and 60 years old?
- Do you have a health insurance plan?
- Do you have any metal implants or devices in your body?
- Have you ever had a seizure or been diagnosed with epilepsy?
- Are you currently pregnant or breastfeeding?
- Have you had any issues with drug or alcohol misuse in the recent past?
What does participation involve?
If you decide to join this study, you'll be one of 40 healthy volunteers. You'll be randomly put into one of two groups. One group will receive stimulation that aims to increase brain activity, while the other will receive stimulation that aims to decrease it.
You'll visit the study site three times, and the order of these visits will be random. During each visit, you'll receive a different type of stimulation: one session will target Lobule VIII in your brain, another will target CRUS I/II, and the third will be a placebo (dummy) stimulation that feels similar but doesn't actually affect your brain.
During each of these sessions, researchers will use special brain scans called fMRI (functional Magnetic Resonance Imaging) and ask you to complete tasks on a computer. These tests help them see how the stimulation changes your brain's connections and how well you perform on activities that involve movement and thinking. The total duration of your participation will depend on the scheduling of these three visits.
Potential risks and benefits
Locations (1)
- Hôpitaux Universitaires de StrasbourgVerified postcodeStrasbourg, France
Common questions
What is rTMS?
rTMS stands for repetitive Transcranial Magnetic Stimulation. It's a non-invasive way to stimulate brain cells using magnetic fields, without surgery or needles.
Is rTMS safe?
Yes, rTMS is generally considered safe. The most common side effects are mild headaches, which usually don't last long.
What is the cerebellum?
The cerebellum is a major part of your brain located at the back of your head. It helps with movement, balance, and even some thinking processes.
Will I feel any pain during the study?
You might feel a tapping sensation on your head from the rTMS or hear clicking sounds. Sometimes people get mild headaches, but significant pain is not expected.
Will my brain be affected permanently?
No, the effects of the stimulation in this study are expected to be temporary and not cause any lasting changes to your brain.
How to find out more
Anne GIERSCH
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.